Cognex (NASDAQ: CGNX) CEO exercises RSUs, withholds shares to cover taxes
Rhea-AI Filing Summary
Cognex Corporation CEO & President Matthew Moschner reported equity compensation activity involving restricted stock units and related tax withholding. On February 20 and 21, 2026, restricted stock units covering 3,042 and 3,495 shares were exercised into an equal number of Cognex common shares at $0.00 per share.
To satisfy tax withholding obligations on these vesting awards, 893 and 1,026 common shares were automatically withheld at a price of $56.03 per share, as described in the footnotes. After these transactions, Moschner held 16,465 shares of Cognex common stock directly, along with multiple outstanding non-qualified stock options and additional restricted stock units.
Positive
- None.
Negative
- None.
Insights
Routine vesting of RSUs with tax withholding; no open-market trades.
The transactions show Matthew Moschner converting restricted stock units into Cognex common stock and having a portion of those shares withheld to cover tax obligations. Code M entries reflect derivative exercises at $0.00 per share, typical for RSU vesting.
Code F entries at $56.03 per share are explicitly described as shares withheld for taxes, not discretionary sales. The Form 4 also lists sizeable outstanding non-qualified stock options and additional restricted stock units, but these rows simply update current holdings rather than signaling new market transactions.
Overall, the filing documents standard executive equity compensation mechanics rather than directional buying or selling in the open market. Its informational value lies in clarifying Moschner’s current direct ownership of 16,465 common shares and his remaining option and RSU awards for future potential equity delivery.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 3,495 | $0.00 | -- |
| Exercise | Common Stock | 3,495 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,026 | $56.03 | $57K |
| Exercise | Restricted Stock Unit | 3,042 | $0.00 | -- |
| Exercise | Common Stock | 3,042 | $0.00 | -- |
| Tax Withholding | Common Stock | 893 | $56.03 | $50K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Footnotes (1)
- This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein. This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.
